Clinical Trial Update: Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical trials evaluating nicotine lozenge and tobacco-free snuff for reducing smokeless tobacco use have completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Dependence

Drugs mentioned

• Nicotine lozenge (nicotine lozenge)
• Tobacco-free snuff

Snippet

Sponsor: Mayo Clinic | Conditions: Tobacco Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-09-13